Factors associated with severe illness in pandemic 2009 influenza a (H1N1) infection: Implications for triage in primary and secondary care

Journal of Infection

Volumn 63, Issue 4, 2011, Pages 243-251

  Singanayagam, Anika ^a   Singanayagam, Aran ^b   Wood, Victoria ^c   Chalmers, James D ^c  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

H1N1 subtype; Human; Influenza; Influenza A virus; Severity of illness index

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE; LACTATE DEHYDROGENASE; NITRIC OXIDE; PROCALCITONIN;

2009 H1N1 INFLUENZA; ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ADVERSE OUTCOME; AGE DISTRIBUTION; ARTIFICIAL VENTILATION; CHRONIC LUNG DISEASE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DISEASE TRANSMISSION; EXTRACORPOREAL OXYGENATION; HEALTH CARE; HIGH RISK POPULATION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; LABORATORY TEST; MORTALITY; OBESITY; PANDEMIC; PATIENT CODING; PNEUMONIA; PRACTICE GUIDELINE; PREGNANCY; PRIMARY MEDICAL CARE; RESPIRATORY FAILURE; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SECONDARY HEALTH CARE; SEPSIS; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TREATMENT PLANNING; VITAL SIGN;

HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; PANDEMICS; RISK FACTORS;

EID: 80052947745     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.07.014     Document Type: Review

References (79)

1. (WHO) WHO. World now at the start of 2009 influenza pandemic. [cited 2011 22nd January 2011]; Available from: http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html.
2. Pandemic (H1N1) 2009-update 76 2009, World Health Organisation W, [cited 2011 22nd January]; Available from. http://www.who.int/csr/don/2009_11_27a/en/index.html.
3. ECDC daily update - pandemic (H1N1) 2009 - 18 January 2010 2010, European Centre for Disease Prevention and Control E, [cited 2011 24th January]; Available from. http://ecdc.europa.eu/100118_Influenza_AH1N1_Situation_Report_0900hrs.pdf.
4. Nguyen-Van-Tam J., Openshaw P., Hashim A., Gadd E., Lim W., Semple M., et al. Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (Mayñ September 2009). Thorax 2010, 65(7):645.
5. Clinical management of human infection with pandemic (H1N1) 2009: revised guidance 2009, World Health Organisation W, [cited 2011 22nd January]; Available from. http://www.who.int/csr/resources/publications/swineflu/clinical_management/en/index.html.
6. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. New England Journal of Medicine 2010, 362(18):1708-1719.
7. HPA weekly national influenza report - week 2 2011, Health Protection Agency H, [cited; Available from. http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1294739353955.
8. Singanayagam A., Chalmers J., Hill A. Severity assessment in community-acquired pneumonia: a review. QJM 2009.
9. Lim W. Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. British Medical Journal 2007, 62(Supplement 1):1.
10. (DoH) DoH. Swine Flu Clinical Package. [cited 2009 12th October]; Available from: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_100941.
11. Webb S., Pettila V., Seppelt I., Bellomo R., Bailey M., Cooper D., et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. New England Journal of Medicine 2009, 361(20):1925-1934.
12. Dominguez-Cherit G., Lapinsky S., Macias A., Pinto R., Espinosa-Perez L., de la Torre A., et al. Critically ill patients with 2009 influenza A (H1N1) in Mexico. Jama 2009, 302(17):1880.
13. Jain S., Kamimoto L., Bramley A., Schmitz A., Benoit S., Louie J., et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. New England Journal of Medicine 2009, 361(20):1935.
14. Kumar A., Zarychanski R., Pinto R., Cook D.J., Marshall J., Lacroix J., et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA: The Journal of the American Medical Association November 4, 2009, 302(17):1872-1879.
15. Miller R., Markewitz B., Rolfs R., Brown S., Dascomb K., Grissom C., et al. Clinical findings and demographic factors associated with intensive care unit admission in Utah due to 2009 novel influenza A (H1N1) infection. Chest 2009.
16. Rello J., RodrÌguez A., IbaÒez P., Socias L., Cebrian J., Marques A., et al. Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1) v in Spain. Critical Care 2009, 13(5):R148.
17. Nicolay N., Callaghan M., Domegan L., Oza A., Marsh B., Flanagan P., et al. Epidemiology, clinical characteristics and resource implications of pandemic (H1N1) 2009 in intensive care units in Ireland. Critical Care and Resuscitation: Journal of the Australasian Academy of Critical Care Medicine 2010, 12(4):255.
18. Ugarte S., Arancibia F., Soto R. Influenza A pandemics: clinical and organizational aspects: the experience in Chile. Critical Care Medicine 2010, 38:e133.
19. Zarychanski R., Stuart T., Kumar A., Doucette S., Elliott L., Kettner J., et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. Canadian Medical Association Journal 2010, 182(3):257.
20. Chudasama R., Verma P., Amin C., Gohel B., Savariya D., Ninama R. Correlates of severe disease in patients admitted with 2009 pandemic influenza A (H1N1) infection in Saurashtra region, India. Indian Journal of Critical Care Medicine 2010, 14(3):113.
21. Donaldson L., Rutter P., Ellis B., Greaves F., Mytton O., Pebody R., et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. British Medical Journal 2009, 339(dec10 1):b5213.
22. Louie J., Acosta M., Winter K., Jean C., Gavali S., Schechter R., et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. Jama 2009, 302(17):1896.
23. Kim H., Kim J., Shin S., Kang Y., Lee H., Kim J., et al. Fatal cases of 2009 pandemic influenza A (H1N1) in Korea. Journal of Korean Medical Science 2011, 26(1):22.
24. Kute V, Godara S, Goplani K, Gumber M, Shah P, Vanikar A, et al. High mortality in critically ill patients infected with 2009 pandemic influenza A (H1N1) with pneumonia and acute kidney injury. Saudi Journal of Kidney Diseases and Transplantation: an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 22(1):83.
25. Wilking H., Buda S., von der Lippe E., Altmann D., Krause G., Eckmanns T., et al. Mortality of 2009 pandemic influenza A (H1N1) in Germany. Euro Surveill 2010, 15:49.
26. Campbell A., Rodin R., Kropp R., Mao Y., Hong Z., Vachon J., et al. Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. Canadian Medical Association Journal 2010, 182(4):349.
27. Fuhrman C., Bonmarin I., Paty A., Duport N., Chiron E., Lucas E., et al. Severe hospitalised 2009 pandemic influenza A (H1N1) cases in France, 1 July-15 November 2009. Euro surveillance: Bulletin EuropÈen Sur les Maladies Transmissibles=European Communicable Disease Bulletin 2010, 15(2).
28. Pebody R., McLean E., Zhao H., Cleary P., Bracebridge S., Foster K., et al. Pandemic influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill 2010, 15(20).
29. Katz J., Hancock K., Veguilla V., Zhong W., Lu X., Sun H., et al. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. JAMA 2009, 302(3):249-250.
30. EchevarrÌa-Zuno S., MejÌa-ArangurÈ J., Mar-Obeso A., Grajales-MuÒiz C., Robles-PÈrez E., Gonz·lez-LeÛn M., et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. The Lancet 2010, 374(9707):2072-2079.
31. Hughes J.M., Wilson M.E., Lee E.H., Wu C., Lee E.U., Stoute A., et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York City. Clinical Infectious Diseases June 1, 2010, 50(11):1498-1504.
32. Yu H, Feng Z, Uyeki TM, Liao Q, Zhou L, Feng L, et al. Risk Factors for Severe Illness with 2009 Pandemic Influenza A (H1N1) Virus Infection in China. Clinical Infectious Diseases.
33. McGeer A., Green K., Plevneshi A., Shigayeva A., Siddiqi N., Raboud J., et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Chemotherapy 2006, 29.
34. Napolitano L., Park P., Sihler K., Papadimos T., Chenoweth C., Cinti S., et al. Intensive-care patients with severe novel influenza A (H1N1) virus infectionó Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009, 58(27):749-752.
35. Johnston S., Pattemore P., Sanderson G., Smith S., Lampe F., Josephs L., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. British Medical Journal 1995, 310(6989):1225.
36. Wark P., Johnston S., Bucchieri F., Powell R., Puddicombe S., Laza-Stanca V., et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. The Journal of Experimental Medicine 2005, 201(6):937.
37. Contoli M. Role of deficient type III interferon- production in asthma exacerbations. Nature Medicine 2006, 12(9):1023-1026.
38. Carlson A., Thung S., Norwitz E. H1N1 influenza in pregnancy: what all obstetric care providers ought to know. Reviews in Obstetrics and Gynecology 2009, 2(3):139.
39. Cui W, Zhao H, Lu X, Wen Y, Zhou Y, Deng B, et al. Research article Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China. 2010.
40. Hedlund J., Hansson L., Ortqvist A. Short-and long-term prognosis for middle-aged and elderly patients hospitalized with community-acquired pneumonia: impact of nutritional and inflammatory factors. Scandinavian Journal of Infectious Diseases 1995, 27(1):32-37.
41. Ho Y., Wang J., Wang J., Wu U., Chang C., Wu H., et al. Prognostic factors for fatal adult influenza pneumonia. Journal of Infection 2009, 58(6):439-445.
42. Jamieson D., Honein M., Rasmussen S., Williams J., Swerdlow D., Biggerstaff M., et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009, 374(9688):451-458.
43. Dodds L., McNeil S., Fell D., Allen V., Coombs A., Scott J., et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. Canadian Medical Association Journal 2007, 176(4):463.
44. Harris J. Influenza occurring in pregnant women: a statistical study of thirteen hundred and fifty cases. Jama 1919, 72(14):978.
45. Freeman D., Barno A. Deaths from Asian influenza associated with pregnancy. Obstetrical & Gynecological Survey 1960, 15(2):212.
46. Davies A., Jones D., Bailey M., Beca J., Bellomo R., Blackwell N. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome. Jama 2009, 302(17):1888.
47. Allard R., Leclerc P., Tremblay C., Tannenbaum T.N. Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care 2010, 33(7):1491-1493.
48. Perez-Padilla R., de la Rosa-Zamboni D., Ponce de Leon S., Hernandez M., QuiÒones-Falconi F., Bautista E., et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. New England Journal of Medicine 2009, 361(7):680.
49. Patel M., Dennis A., Flutter C., Thornton S., D'Mello O., Sherwood N. Pandemic (H1N1) 2009 influenza: experience from the critical care unit. Anaesthesia 2009, 64(11):1241-1245.
50. Miller A.C., Subramanian R.A., Safi F., Sinert R., Zehtabchi S., Elamin E.M. Influenza A 2009 (H1N1) virus in admitted and critically ill patients. Journal of Intensive Care Medicine 2011.
51. Abe M., Higuchi T., Okada K., Kaizu K., Matsumoto K. Clinical study of influenza-associated rhabdomyolysis with acute renal failure. Clinical Nephrology 2006, 66(3):166.
52. Wiwanitkit V. Hemostatic disorders in bird flu infection. Blood Coagulation & Fibrinolysis 2008, 19(1):5.
53. Chalmers J., Singanayagam A., Hill A. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. The American Journal of Medicine 2008, 121(3):219-225.
54. MenÈndez R., Cavalcanti M., Reyes S., Mensa J., Martinez R., Marcos M., et al. Markers of treatment failure in hospitalised community acquired pneumonia. Thorax 2008, 63(5):447.
55. Kŗger S., Ewig S., Marre R., Papassotiriou J., Richter K., von Baum H., et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. European Respiratory Journal 2008, 31(2):349.
56. Masi· M., GutiÈrrez F., Shum C., Padilla S., Navarro J., Flores E., et al. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index*. Chest 2005, 128(4):2223.
57. Niederman M. Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on Procaldtonin. Clinical Infectious Diseases 2008, 47.
58. MenÈndez R., Martinez R., Reyes S., Mensa J., Filella X., Marcos M., et al. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax 2009, 64(7):587.
59. Zimmerman O., Rogowski O., Aviram G., Mizrahi M., Zeltser D., Justo D., et al. C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H 1 N 1 influenza A virus infection. BMC Infectious Diseases 2010, 10(1):288.
60. This N. Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Thorax 2007, 62:i1-i13.
61. Swine flu clinical package 2009, Department of Health D, [cited 2011 18th January]; Available from. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_106495.
62. Knaus W., Draper E., Wagner D., Zimmerman J. APACHE II: a severity of disease classification system. Critical Care Medicine 1985, 13(10):818.
63. Knaus W., Zimmerman J., Wagner D., Draper E., Lawrence D. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Critical Care Medicine 1981, 9(8):591.
64. Vincent J., Moreno R., Takala J., Willatts S., De Mendonca A., Bruining H., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Medicine 1996, 22(7):707-710.
65. Lim W., Van der Eerden M., Laing R., Boersma W., Karalus N., Town G., et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003, 58(5):377.
66. Lim W., Baudouin S., George R., Hill A., Jamieson C., Le Jeune I., et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. British Medical Journal 2009, 64(Suppl 3).
67. Lim W. Severity assessment in community-acquired pneumonia: moving on. British Medical Journal 2007, 62(4):287.
68. Louie J., Jean C., Chen T., Park S., Ueki R., Harper T., et al. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)-United States, May-August 2009. MMWR 2009, 58(38):1071-1074.
69. Chalmers J., Singanayagam A., Hill A. Predicting the need for mechanical ventilation and/or inotropic support for young adults admitted to the hospital with community-acquired pneumonia. Clinical Infectious Diseases 2008, 47(12):1571-1574.
70. McCartney C., Cookson B., Dance D., Day C., Duerden B., Elston T., et al. Interim guidance on diagnosis and management of Panton-Valentine Leukocidin-associated Staphylococcal infections in the UK 2006, Department of Health, London.
71. Mulrennan S., Tempone S.S., Ling I.T.W., Williams S.H., Gan G.C., Murray R.J., et al. Pandemic influenza (H1N1) 2009 pneumonia: CURB-65 score for predicting severity and nasopharyngeal sampling for diagnosis are unreliable. PLoS One 2010, 5(9):680-689.
72. Goodacre S., Challen K., Wilson R., Campbell M. Evaluation of triage methods used to select patients with suspected pandemic influenza for hospital admission: cohort study. Health Technology Assessment 2010, 14(46).
73. Rowan K., Harrison D., Walsh T., McAuley D., Perkins G., Taylor B., et al. The Swine Flu Triage (SwiFT) study: development and ongoing refinement of a triage tool to provide regular information to guide immediate policy and practice for the use of critical care services during the H1N1 swine influenza pandemic. Health Technology Assessment (Winchester, England) 2010, 14(55):335.
74. Bewick T., Myles P., Greenwood S., Nguyen-Van-Tam J.S., Brett S.J., Semple M.G., et al. Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults. Thorax 2011, 66(3):247.
75. Riquelme R., Jimenez P., Videla A., Lopez H., Chalmers J., Singanayagam A., et al. Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia. The International Journal of Tuberculosis and Lung Disease 2011, 15(4):542-546.
76. Barlow G. Swine flu and antibiotics. Journal of Antimicrobial Chemotherapy 2009, 64(5):889.
77. Pandemic H1N1 2009 influenza: clinical management guidelines for adults and children 2009, Department of Health D, [cited 2011 18th January]; Available from. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_107769.
78. Influenza Season Triage Algorithm for adults (older than 18 years of age) with influenza-like illness 2009-2010, US Centers for disease control and Prevention C, [cited 2009 12th December]; Available from. http://www.cdc.gov/h1n1flu/clinicians/pdf/adultalgorithm.pdf.
79. Cheng A., Dwyer D., Kotsimbos A., Starr M., Korman T., Buttery J., et al. Summary of the Australasian Society for Infectious Diseases and the Thoracic Society of Australia and New Zealand guidelines: treatment and prevention of H1N1 influenza 09 (human swine influenza) with antiviral agents. The Medical Journal of Australia 2009, 191(3):142.